Clinical Outcomes of High-dose Intravenous Nitroglycerin in Sympathetic Crashing Acute Pulmonary Edema
Authors:
Open Access
- 16 July 2026
- journal article
- Published by Wolters Kluwer Health in Journal of Emergencies, Trauma, and Shock
- Vol. 19 (3) , 144-149
Abstract
Introduction: Sympathetic Crashing Acute Pulmonary Edema (SCAPE) is a life-threatening form of acute heart failure requiring immediate management with noninvasive ventilation (NIV) and vasodilator therapy. Although nitroglycerin (NTG) is commonly used, optimal dosing remains uncertain. Emerging evidence suggests high-dose NTG may provide rapid clinical improvement. We aimed to evaluate the safety and efficacy of high-dose intravenous NTG in patients presenting with SCAPE to the emergency department (ED). Methods: We conducted a prospective observational study in a high-volume, busy ED, enrolling adults (>18 years) meeting established diagnostic criteria for SCAPE who received an initial intravenous NTG bolus ≥400 μg. Patients with acute coronary syndrome, trauma, recent phosphodiesterase V inhibitor use, or significant aortic stenosis were excluded. Clinical status and outcomes were assessed at 3, 6, and 12 h, and at ED disposition. The primary objective was clinical outcomes (symptom resolution, need for intubation, and ED disposition) of SCAPE patients. Results: Sixty-one patients were included. The mean NTG bolus dose was 830 μg. One patient (1.6%) developed hypotension requiring fluids and brief inotropic support. Headache occurred in five patients (8.2%). Symptom resolution was observed in 10 patients (16%) at 3 h, 32 (52.5%) at 6 h, and 55 (90%) at 12 h. Five patients (8.2%) required intubation. Overall, 41 patients (67.2%) were discharged directly from the ED. The mean ED length of stay was 14 h. Conclusion: High-dose intravenous NTG may improve clinical outcomes in the acute management of SCAPE, with rapid symptom resolution and reduced need for intubation. Larger studies are warranted to confirm these findings and to standardise dosing protocols.Keywords
This publication has 15 references indexed in Scilit:
- Taming the Tiger: Ultra high dose nitroglycerin in managing sympathetic crashing acute pulmonary edema patientThe American Journal of Emergency Medicine, 2023
- High-dose nitroglycerin infusion description of safety and efficacy in sympathetic crashing acute pulmonary edema: The HI-DOSE SCAPE studyThe American Journal of Emergency Medicine, 2022
- High-Dose Nitroglycerin Bolus for Sympathetic Crashing Acute Pulmonary Edema: A Prospective Observational Pilot StudyThe Journal of Emergency Medicine, 2021
- High-dose nitroglycerin infusion for the management of sympathetic crashing acute pulmonary edema (SCAPE): A case seriesThe American Journal of Emergency Medicine, 2021
- Role of high-dose intravenous nitrates in hypertensive acute heart failureThe American Journal of Emergency Medicine, 2020
- Lung Ultrasound in Acute Heart FailureJACC: Heart Failure, 2019
- Recognition of Sympathetic Crashing Acute Pulmonary Edema (SCAPE) and use of high-dose nitroglycerin infusionThe American Journal of Emergency Medicine, 2018
- Use of nitroglycerin by bolus prevents intensive care unit admission in patients with acute hypertensive heart failureThe American Journal of Emergency Medicine, 2017
- Treatment of Severe Decompensated Heart Failure With High-Dose Intravenous Nitroglycerin: A Feasibility and Outcome AnalysisAnnals of Emergency Medicine, 2007
- The Use of Noninvasive Ventilation in Emergency Department Patients With Acute Cardiogenic Pulmonary Edema: A Systematic ReviewAnnals of Emergency Medicine, 2006